Condensed Consolidated Interim Financial Statements as of March 31, 2016

Bayer Group
Consolidated Income Statements

 

 

Q1 2015

 

Q1 2016

 

 

€ million

 

€ million

2015 figures restated

1

EBIT = earnings before financial result and taxes

Net sales

 

11,879

 

11,941

Cost of goods sold

 

(5,476)

 

(5,086)

Gross profit

 

6,403

 

6,855

Selling expenses

 

(2,920)

 

(2,914)

Research and development expenses

 

(946)

 

(1,110)

General administration expenses

 

(471)

 

(497)

Other operating income

 

247

 

203

Other operating expenses

 

(369)

 

(202)

EBIT1

 

1,944

 

2,335

Equity-method loss

 

6

 

(5)

Financial income

 

12

 

37

Financial expenses

 

(292)

 

(347)

Financial result

 

(274)

 

(315)

Income before income taxes

 

1,670

 

2,020

Income taxes

 

(375)

 

(478)

Income from continuing operations after income taxes

 

1,295

 

1,542

Income from discontinued operations after income taxes

 

45

 

39

Income after income taxes

 

1,340

 

1,581

of which attributable to noncontrolling interest

 

6

 

70

of which attributable to Bayer AG stockholders (net income)

 

1,334

 

1,511

 

 

 

 

 

 

 

 

Earnings per share

 

 

 

 

From continuing operations

 

 

 

 

Basic

 

1.56

 

1.78

Diluted

 

1.56

 

1.78

From discontinued operations

 

 

 

 

Basic

 

0.06

 

0.05

Diluted

 

0.06

 

0.05

From continuing and discontinued operations

 

 

 

 

Basic

 

1.62

 

1.83

Diluted

 

1.62

 

1.83